150
Participants
Start Date
November 25, 2023
Primary Completion Date
December 1, 2026
Study Completion Date
May 31, 2027
Zoledronate
intravenous infusion
Denosumab
subcutaneous injection
Teriparatide
subcutaneous injection
Romosozumab
subcutaneous injection
Abaloparatide Injection (80 mcg)
daily subcutaneous injection
RECRUITING
251 Airforce & VA General Hospital, Athens
RECRUITING
First Department of Propaedeutic and Internal Medicine, Medical School, National and Kapodistrian University of Athens, Athens
RECRUITING
, KAT General Hospital, Athens
RECRUITING
Department of Medicine, Surgery and Neurosciences, University of Siena, Siena
RECRUITING
424 General Military Hospital, Thessaloniki
RECRUITING
Fondazione IRCCS Cà Granda-Ospedale Maggiore Policlinico, Milan
RECRUITING
University-Hospital S. Maria della Misericordia, Udine
RECRUITING
Campus Bio-Medico University, Roma
424 General Military Hospital
OTHER